Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

Reusable smart device pens also work alongside a companion app to track dosages and provide much-needed data to help manage diabetes. Smart insulin pens can also: Calculate the needed dose based ...

2. Smart Insulin Pens: These devices record insulin doses and timing, helping patients manage their diabetes more effectively. Data from smart pens can be shared with healthcare providers to ...

as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose ...

The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device that stores and transfers insulin dose-related data from the pen ...

The market is also benefiting from advancements in insulin pen technologies, including the integration of smart features such as dose tracking and connectivity to digital health platforms. These ...

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to list on the Nasdaq under the symbol “BBNX.” ...

The trade show floor offers a firsthand look at how market trends shape current design and manufacturing innovations.